Skip to main content
NC State Home
Wolfpack Investor Network

Link to External News

Oct 27, 2025

Forever Ends Here

Forever Ends Here is a cinematic short film about Invicta Water’s breakthrough technology that doesn’t just filter PFAS... it destroys it, for good. Filmed in North Carolina, this story reveals how Invicta’s team set out to solve the unsolvable and built the world’s first all-in-one system that captures, concentrates, and destroys “forever chemicals” (PFAS) forever.

Aug 22, 2025

Here are the “Angel Deals of the Week” from today’s issue of The Diligent Observer:

Eventuall is developing a platform for virtual fan engagement designed for talent-driven online events, differentiating from general-purpose platforms like Zoom or Twitch through ticketed personalized interactions. The Los Angeles-based company features advanced production tools and patented systems for backstage management and participant vetting, targeting safety, scalability, and monetization for creators. The company recently secured $250,000+ in follow-on funding from the Wolfpack Investor Network to complete its Self-Service MVP and onboard talent.

Aug 1, 2025

Basic Research Leads to Market’s First All-Natural, EPA-Registered Insect Repellent

Mimikai’s repellent leverages the active ingredient undecanone — a naturally occurring chemical compound found in tomatoes, bananas and other fruits. The company’s groundbreaking product has been certified by the EPA to protect against mosquitoes for up to eight hours and against ticks for up to four hours.

Jul 31, 2025

Here are the “Angel Deals of the Week” from today’s issue of The Diligent Observer:

Invicta Water is developing a continuous flow system that removes and destroys PFAS contamination from drinking water, wastewater, and industrial runoff in a single process.

Jul 30, 2025

Cary pilot targets PFAs in drinking water

Invicta Water's Jordan Lake pilot has treated 11 million gallons, claiming to erase PFAS with no toxic waste. Cary will judge fall test data to see if it's a cheaper fix than carbon filters.

Jul 30, 2025

Cary testing way to remove ‘forever chemicals’ from Jordan Lake without waste

A blue shipping container perched on the shore of Jordan Lake hums day and night, pulling raw, muddy water into a maze of stainless steel pipes. Since April 1, the skid‑mounted system has treated nearly 11 million gallons, according to Steve Wilcenski, chief executive and co‑founder of Invicta Water. It is a pilot program, testing a new way to remove toxic chemicals from the water.

Apr 17, 2025

SonoVascular wins Angel Capital Association 2025 Luis Villalobos Award

SonoVascular, Inc., a clinical stage medical device company focused on bringing to market its SonoThrombectomy™ System, a safer and more effective treatment of venous thromboembolism (VTE), was awarded the Angel Capital Association's 2025 Luis Villalobos Award in the Life Science category at the Summit of Angel Investing conference in Denver, CO.

Apr 17, 2025

WIN Portfolio Company SonoVascular Wins ACA’s 2025 Luis Villalobos Award

The Angel Capital Association (ACA), the world’s largest professional development organization for angel investors, representing over 15K angel investors, 250 angel groups, and +30K entrepreneurial companies, awarded SonoVascular, a Wolfpack Investor Network (WIN) portfolio company, the 2025 Luis Villalobos Award in the Life Sciences category.

Mar 27, 2025

VQ Biomedical raises $5M for a new treatment for lung injuries

Full Article by Zachery Eanes for Axios Raleigh - VQ Biomedical, a startup born at Duke University, has secured $5 million in funding to advance a device it says will treat severe lung injuries in a less invasive way.

Nov 5, 2024

NC State investment arm looks to grow platform, fund more startups

The Wolfpack Investor Network (WIN) and Harbright Ventures are excited to announce a follow-on investment of over $1.75M in SonoVascular, a medical technology company that has developed SonoThrombectomy™, a novel, pharmaco-mechanical, ultrasound-facilitated, and thrombolytic-enhanced thrombectomy system for venous thromboembolism (VTE).